---
schema_version: "secwatch.filing_event.v1"
accession: "0001867096-26-000048"
form_type: "8-K"
ticker: "XERS"
cik: "0001867096"
company_name: "Xeris Biopharma Holdings, Inc."
filed_at: "2026-06-30T20:06:32+00:00"
generated_at: "2026-06-30T20:07:07.860215+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Xeris appoints Nerissa Kreher to board; CEO John Shannon named Chair

## Summary
- Dr. Nerissa Kreher appointed to board effective July 1, 2026, expanding board to eight members.
- CEO John Shannon named Chair of the Board effective July 1, 2026.
- Marla Persky transitions to Lead Independent Director.
- Dr. Kreher is CMO of Alltrna and has over 20 years of rare disease experience.
- Dr. Kreher received initial equity award of ~$450,000 in options and RSUs.

## SEC filing metadata
- accession: 0001867096-26-000048
- form_type: 8-K
- ticker: XERS
- cik: 0001867096
- company_name: Xeris Biopharma Holdings, Inc.
- filed_at: 2026-06-30T20:06:32+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867096/000186709626000048/0001867096-26-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867096/000186709626000048/xers-20260629.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001867096-26-000048
- JSON: https://secwatch.observer/filing/0001867096-26-000048.json
- Plain text: https://secwatch.observer/filing/0001867096-26-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.